Dr. Veena Panicker, Director - BioMonitoring, Merck Life Science in a recent interaction with India Pharma Outlook shared her views on how the growing consumer demand for safer, higher-quality food...
By:Dr. Veena Panicker, Director - BioMonitoring, Merck Life Science
BY:Kapil Choudhury, Head of Global Business Development, Aurigene Pharmaceutical Services
In an exclusive interview with India Pharma Outlook Magazine,Kapil Choudhury, Head of Global Business Development, Aurigene Pharmaceutical...
BY:Dr. Dyotona Sen, Head - Medical Affairs and Clinical Research, Galderma
In an interaction with India Pharma Outlook, Dr. Dyotona Sen, Head of Medical Affairs and Clinical Research at Galderma, emphasizes Medical Affairs...
BY:Nakul Verma, Senior Director, Sanofi
In the ASSOCHAM Annual Pharma Summit 2024, Nakul Verma, Senior Director, Sanofi, shares industry analysis of the emerging pharmaceutical landscape....
By:Rejith P R, Correspondent, India Pharma Outlook
Alembic Pharmaceuticals has received final approval from the US FDA for its generic Diltiazem Hydrochloride extended-release capsules, which are...
BY:Rejith P R, Correspondent, India Pharma Outlook
Lindy Biosciences, a protein therapeutic formulations firm, has announced a partnership with...
BY:Janifha Evangeline, Assistant Editor, India Pharma Outlook
Owing to the direct impact of its products on public health & safety, the pharma sector...
BY:Janifha Evangeline, Assistant Editor, India Pharma Outlook
A few months ago, lawmakers in Europe signed off on an update to the urban waste water...
Computer aided drug design (CADD) has played a pivotal role in...
A milestone has been achieved by Fortis Hospital, Bengaluru...
India has successfully performed the first human clinical...
.jpg "Usage of Conversational AI in the Health Insurance Sector")
At the Conversational AI and Customer Experience summit last...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
.jpg "Why Adapting Flexibility in IP Rights will Drive Generics Market")
.jpg "Meeting the Challenges of High-Potency API (HPAPI) Production")
